⌘K
Loading ticker…
As of 2026-08-25, MAIA Biotechnology, Inc. (MAIA) has a 3-month relative strength percentile of 60 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.6%, relative volume 2.85×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
MAIA is in a stage 1 base, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 2.9% / -4.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
MAIA is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional.
Held by 3 ETFs · $3M across latest filings · largest weight 0.01% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M | — |
| VXFVanguard Extended Market ETF | 0.00% | $458K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MAIA Jan avg: 28.57% median: 30.91% win: 75% σ: 25.78% n: 4 2022-07-29 → 2026-07-31 | MAIA Feb avg: -6.08% median: -5.83% win: 25% σ: 5.19% n: 4 2022-07-29 → 2026-07-31 | MAIA Mar avg: -2.68% median: -20.30% win: 25% σ: 47.84% n: 4 2022-07-29 → 2026-07-31 | MAIA Apr avg: 13.05% median: 14.09% win: 50% σ: 36.89% n: 4 2022-07-29 → 2026-07-31 | MAIA May avg: 11.19% median: 3.07% win: 75% σ: 36.21% n: 4 2022-07-29 → 2026-07-31 | MAIA Jun avg: -8.96% median: -5.72% win: 50% σ: 14.38% n: 4 2022-07-29 → 2026-07-31 | MAIA Jul avg: -0.11% median: -5.56% win: 40% σ: 17.83% n: 5 2022-07-29 → 2026-07-31 | MAIA Aug avg: -14.87% median: -13.53% win: 0% σ: 13.33% n: 4 2022-07-29 → 2026-07-31 (current) | MAIA Sep avg: 0.01% median: -3.78% win: 25% σ: 18.68% n: 4 2022-07-29 → 2026-07-31 | MAIA Oct avg: -3.96% median: -3.49% win: 25% σ: 12.45% n: 4 2022-07-29 → 2026-07-31 | MAIA Nov avg: -18.92% median: -12.67% win: 25% σ: 23.71% n: 4 2022-07-29 → 2026-07-31 | MAIA Dec avg: 7.78% median: 5.93% win: 50% σ: 18.81% n: 4 2022-07-29 → 2026-07-31 |